$1.83 Billion is the total value of ARMISTICE CAPITAL, LLC's 69 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 76.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $451,968,000 | +20.6% | 1,600,000 | +6.7% | 24.74% | -12.9% |
| CERC | Buy | CERECOR INC | $106,897,000 | +82.6% | 18,304,285 | +1.0% | 5.85% | +31.8% |
| CVS | Buy | CVS HEALTH CORPcall | $74,913,000 | +471.7% | 1,250,000 | +525.0% | 4.10% | +312.9% |
| ENR | Buy | ENERGIZER HLDGS INC NEW | $58,229,000 | +20.8% | 1,296,000 | +21.3% | 3.19% | -12.8% |
| CELG | New | CELGENE CORP | $55,849,000 | – | 592,000 | +100.0% | 3.06% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $53,236,000 | – | 425,000 | +100.0% | 2.91% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $52,122,000 | -42.4% | 2,100,000 | -58.3% | 2.85% | -58.4% |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $42,710,000 | +49.7% | 3,316,000 | +76.6% | 2.34% | +8.1% |
| EPC | Sell | EDGEWELL PERS CARE CO | $42,661,000 | +12.0% | 972,000 | -4.7% | 2.34% | -19.1% |
| PCRX | New | PACIRA PHARMACEUTICALS INC | $40,800,000 | – | 1,072,000 | +100.0% | 2.23% | – |
| FTDR | Buy | FRONTDOOR INC | $38,963,000 | +144.0% | 1,132,000 | +88.7% | 2.13% | +76.3% |
| HAIN | New | HAIN CELESTIAL GROUP INCcall | $36,992,000 | – | 1,600,000 | +100.0% | 2.02% | – |
| DFRG | Buy | DEL FRISCOS RESTAURANT GROUP | $35,896,000 | +10.9% | 5,600,000 | +23.7% | 1.96% | -19.9% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $35,533,000 | +0.3% | 372,000 | -25.6% | 1.94% | -27.5% |
| BIIB | New | BIOGEN INC | $35,457,000 | – | 150,000 | +100.0% | 1.94% | – |
| WBT | Buy | WELBILT INC | $32,760,000 | +67.7% | 2,000,000 | +13.8% | 1.79% | +21.1% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $32,610,000 | -10.3% | 1,500,000 | -34.8% | 1.78% | -35.2% |
| TGT | Buy | TARGET CORP | $32,104,000 | +385.8% | 400,000 | +300.0% | 1.76% | +250.7% |
| BURL | New | BURLINGTON STORES INC | $31,336,000 | – | 200,000 | +100.0% | 1.72% | – |
| ATRS | ANTARES PHARMA INC | $31,209,000 | +11.4% | 10,300,000 | 0.0% | 1.71% | -19.5% | |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $29,399,000 | +10.3% | 1,536,000 | -45.8% | 1.61% | -20.3% |
| AZO | Buy | AUTOZONE INC | $28,675,000 | +113.8% | 28,000 | +75.0% | 1.57% | +54.4% |
| PLYA | Sell | PLAYA HOTELS & RESORTS NV | $27,315,000 | -33.0% | 3,580,000 | -36.9% | 1.50% | -51.6% |
| SJM | SMUCKER J M COcall | $23,300,000 | +24.6% | 200,000 | 0.0% | 1.28% | -10.0% | |
| CPB | New | CAMPBELL SOUP COcall | $22,878,000 | – | 600,000 | +100.0% | 1.25% | – |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $22,210,000 | +881.9% | 1,128,000 | +1028.0% | 1.22% | +611.1% |
| HD | New | HOME DEPOT INC | $21,492,000 | – | 112,000 | +100.0% | 1.18% | – |
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $20,610,000 | +57.0% | 1,928,000 | +28.5% | 1.13% | +13.4% |
| ADMS | Buy | ADAMAS PHARMACEUTICALS INC | $19,510,000 | +247.2% | 2,744,000 | +317.0% | 1.07% | +150.7% |
| DPLO | New | DIPLOMAT PHARMACY INC | $17,430,000 | – | 3,000,000 | +100.0% | 0.95% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $15,056,000 | +46.2% | 400,000 | +33.3% | 0.82% | +5.6% |
| DKS | New | DICKS SPORTING GOODS INC | $14,724,000 | – | 400,000 | +100.0% | 0.81% | – |
| FIZZ | New | NATIONAL BEVERAGE CORP | $14,317,000 | – | 248,000 | +100.0% | 0.78% | – |
| CLLS | Buy | CELLECTIS S Asponsored ads | $13,352,000 | +36.1% | 728,000 | +23.6% | 0.73% | -1.6% |
| CPB | New | CAMPBELL SOUP CO | $12,659,000 | – | 332,000 | +100.0% | 0.69% | – |
| SBBP | Sell | STRONGBRIDGE BIOPHARMA PLC | $12,410,000 | -3.7% | 2,492,000 | -13.4% | 0.68% | -30.5% |
| SJM | Sell | SMUCKER J M CO | $11,650,000 | -48.1% | 100,000 | -58.3% | 0.64% | -62.5% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $11,385,000 | +12.8% | 2,124,000 | +7.9% | 0.62% | -18.6% |
| BLUE | New | BLUEBIRD BIO INC | $10,698,000 | – | 68,000 | +100.0% | 0.59% | – |
| FUN | Buy | CEDAR FAIR L Pdepositry unit | $10,524,000 | +48.3% | 200,000 | +33.3% | 0.58% | +7.1% |
| JACK | New | JACK IN THE BOX INC | $9,727,000 | – | 120,000 | +100.0% | 0.53% | – |
| NKE | New | NIKE INCcl b | $9,095,000 | – | 108,000 | +100.0% | 0.50% | – |
| FIVE | Buy | FIVE BELOW INC | $8,946,000 | +45.7% | 72,000 | +20.0% | 0.49% | +5.4% |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $7,752,000 | +192.5% | 1,520,000 | +10.1% | 0.42% | +110.9% |
| MRK | New | MERCK & CO INC | $7,586,000 | – | 90,000 | +100.0% | 0.42% | – |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $7,400,000 | +8.2% | 2,500,000 | -41.9% | 0.40% | -21.8% |
| ALIM | ALIMERA SCIENCES INC | $7,352,000 | +47.6% | 6,936,000 | 0.0% | 0.40% | +6.3% | |
| EAT | New | BRINKER INTL INC | $7,278,000 | – | 164,000 | +100.0% | 0.40% | – |
| AMZN | New | AMAZON COM INC | $7,123,000 | – | 4,000 | +100.0% | 0.39% | – |
| OLLI | Sell | OLLIES BARGAIN OUTLT HLDGS I | $6,826,000 | -5.0% | 80,000 | -25.9% | 0.37% | -31.2% |
| VLRX | Buy | VALERITAS HLDGS INC | $6,487,000 | +0.4% | 19,900,000 | +0.3% | 0.36% | -27.6% |
| ALRN | New | AILERON THERAPEUTICS INC | $6,306,000 | – | 3,233,830 | +100.0% | 0.34% | – |
| ZFGN | Buy | ZAFGEN INC | $5,776,000 | -7.2% | 2,108,000 | +67.6% | 0.32% | -33.1% |
| SPOT | New | SPOTIFY TECHNOLOGY S A | $5,552,000 | – | 40,000 | +100.0% | 0.30% | – |
| DBX | New | DROPBOX INCcl a | $5,450,000 | – | 250,000 | +100.0% | 0.30% | – |
| EYEG | Buy | EYEGATE PHARMACEUTICALS INC | $5,433,000 | -32.3% | 17,812,500 | +3.2% | 0.30% | -51.2% |
| PETQ | New | PETIQ INC | $4,963,000 | – | 158,000 | +100.0% | 0.27% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $4,020,000 | – | 300,000 | +100.0% | 0.22% | – |
| TSN | New | TYSON FOODS INCcl a | $3,610,000 | – | 52,000 | +100.0% | 0.20% | – |
| AYTU | Buy | AYTU BIOSCIENCE INC | $3,340,000 | +4127.8% | 2,000,000 | +1900.0% | 0.18% | +2950.0% |
| OVID | Buy | OVID THERAPEUTICS INC | $3,151,000 | -18.6% | 1,780,000 | +11.2% | 0.17% | -41.3% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $2,858,000 | -41.8% | 80,000 | -53.5% | 0.16% | -58.1% |
| SRRA | Sell | SIERRA ONCOLOGY INC | $2,668,000 | +26.3% | 1,560,000 | -2.5% | 0.15% | -8.8% |
| MDGSW | MEDIGUS LTD*w exp 07/23/202 | $2,040,000 | +16.6% | 1,285,715 | 0.0% | 0.11% | -15.8% | |
| BLPH | New | BELLEROPHON THERAPEUTICS INC | $1,894,000 | – | 2,900,000 | +100.0% | 0.10% | – |
| DYNT | Buy | DYNATRONICS CORP | $1,187,000 | -22.5% | 576,000 | +2.7% | 0.06% | -44.0% |
| ROX | Sell | CASTLE BRANDS INC | $697,000 | -21.3% | 1,000,000 | -4.0% | 0.04% | -43.3% |
| NAKD | Sell | NAKED BRAND GROUP LIMITED | $460,000 | -85.9% | 1,462,150 | -62.4% | 0.02% | -89.9% |
| MBRX | New | MOLECULIN BIOTECH INC | $179,000 | – | 220,598 | +100.0% | 0.01% | – |
| RTTR | Exit | RITTER PHARMACEUTICALS INC | $0 | – | -50,771 | -100.0% | -0.00% | – |
| ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -29,216 | -100.0% | -0.01% | – |
| Exit | TENAX THERAPEUTICS INC | $0 | – | -84,590 | -100.0% | -0.01% | – | |
| CUR | Exit | NEURALSTEM INC | $0 | – | -590,000 | -100.0% | -0.01% | – |
| SYN | Exit | SYNTHETIC BIOLOGICS INC | $0 | – | -556,904 | -100.0% | -0.02% | – |
| PULM | Exit | PULMATRIX INC | $0 | – | -1,723,254 | -100.0% | -0.03% | – |
| UAA | Exit | UNDER ARMOUR INCcl a | $0 | – | -30,000 | -100.0% | -0.04% | – |
| ACHV | Exit | ACHIEVE LIFE SCIENCE INC | $0 | – | -448,000 | -100.0% | -0.04% | – |
| CTXR | Exit | CITIUS PHARMACEUTICALS INC | $0 | – | -738,431 | -100.0% | -0.06% | – |
| APRI | Exit | APRICUS BIOSCIENCES INC | $0 | – | -4,600,000 | -100.0% | -0.07% | – |
| ORMP | Exit | ORAMED PHARM INC | $0 | – | -542,944 | -100.0% | -0.12% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.34% | – |
| VICL | Exit | VICAL INC | $0 | – | -4,360,500 | -100.0% | -0.39% | – |
| Exit | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $0 | – | -21,760,000 | -100.0% | -0.43% | – | |
| INCY | Exit | INCYTE CORP | $0 | – | -100,000 | -100.0% | -0.48% | – |
| AAP | Exit | ADVANCE AUTO PARTS INC | $0 | – | -42,000 | -100.0% | -0.50% | – |
| ATEC | Exit | ALPHATEC HOLDINGS INC | $0 | – | -3,338,414 | -100.0% | -0.58% | – |
| MRKR | Exit | MARKER THERAPEUTICS INC | $0 | – | -1,488,000 | -100.0% | -0.63% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -332,000 | -100.0% | -0.67% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -158,000 | -100.0% | -0.78% | – |
| FL | Exit | FOOT LOCKER INC | $0 | – | -212,000 | -100.0% | -0.86% | – |
| ASRT | Exit | ASSERTIO THERAPEUTICS INC | $0 | – | -3,278,000 | -100.0% | -0.90% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -124,000 | -100.0% | -0.92% | – |
| TJX | Exit | TJX COS INC NEW | $0 | – | -300,000 | -100.0% | -1.02% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -5,700,000 | -100.0% | -1.81% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -70,000 | -100.0% | -1.98% | – |
| SRCL | Exit | STERICYCLE INC | $0 | – | -858,000 | -100.0% | -2.39% | – |
| TPX | Exit | TEMPUR SEALY INTL INC | $0 | – | -824,000 | -100.0% | -2.58% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.